| PERIOD ENDING | 31-Jul-09 | 31-Jul-08 | 31-Jul-07 | | Total Revenue | 1,208,702 | 1,523,016 | 1,362,631 | | Cost of Revenue | 631,119 | 778,821 | 705,587 | | | Gross Profit | 577,583 | 744,195 | 657,044 | | | Operating Expenses | | Research Development | 34,181 | 40,607 | 35,954 | | Selling General and Administrative | 397,180 | 495,904 | 449,103 | | Non Recurring | 25,849 |
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 120,373 | 207,684 | 171,987 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,800 | 4,888 | 2,875 | | Earnings Before Interest And Taxes | 122,173 | 212,572 | 174,862 | | Interest Expense | 24,901 | 26,385 | 22,934 | | Income Before Tax | 97,272 | 186,187 | 151,928 | | Income Tax Expense | 27,150 | 53,999 | 42,540 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 70,122 | 132,188 | 109,388 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 70,122 | 132,188 | 109,388 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $70,122 | $132,188 | $109,388 |
|
0.51% Nasdaq 
Income Statement
